The ESP and BDIAP gratefully acknowledge the support of the following companies for the 32nd Congress of the ESP and the XXXIII International Congress of the IAP:
Thermo Fisher Scientific
A. MENARINI DIAGNOSTICS
Daiichi Sankyo Europe GmbH
Daiichi Sankyo is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address unmet medical needs. With more than 100 years of scientific expertise and a presence
in more than 20 countries, Daiichi Sankyo and its 15,000 employees draw upon
a rich legacy of innovation and a robust pipeline of promising new medicines.
Our 2025 Vision is to become a “Global Pharma Innovator with Competitive Advantage in Oncology”. Anchored by our DXd antibody drug conjugate (ADC) technology, our powerful research engines include biologics, medicinal chemistry, modality and other research laboratories. More information: www.daiichi-sankyo.eu.
Ibex Medical Analytics
Innovation Science Press
Primera Technology, Inc.